"BENIPRIME M 25: Comprehensive Cardiovascular Support"

May 20, 2024

BENIPRIME M 25

Benidipine (4mg), Metoprolol Succinate (25mg)

Introduction

Benidipine and Metoprolol Succinate are two potent medications commonly used in managing hypertension and other cardiovascular conditions. Benidipine, a calcium channel blocker, and Metoprolol Succinate, a beta-blocker, work synergistically to provide comprehensive cardiovascular care.

Benidipine (4mg)

Benidipine, at a dosage of 4mg, effectively lowers blood pressure by relaxing blood vessels, making it easier for the heart to pump blood. It is particularly effective in reducing the risk of stroke and heart attack in hypertensive patients.

Metoprolol Succinate (25mg)

Metoprolol Succinate, administered at 25mg, helps in controlling heart rate and reducing the force of heart contractions. This beta-blocker is beneficial for patients with hypertension, angina, and heart failure.

Combined Benefits

The combination of Benidipine and Metoprolol Succinate offers a dual mechanism to control high blood pressure and improve heart health. Benidipine's vasodilatory effects complement Metoprolol's heart rate control, providing an effective treatment for cardiovascular diseases.

Conclusion

Combining Benidipine (4mg) and Metoprolol Succinate (25mg) ensures comprehensive management of hypertension and other heart conditions, improving patient outcomes through a balanced approach to cardiovascular health.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.